Sunanda A. Ranadive - Concepedia

Concepedia

Author

Sunanda A. Ranadive

Bristol-Myers Squibb (United States)

Also Known As

S.A. Ranadive, Sunanda A. Ranadive, Sunanda Ranadive

13

Publications

1.1K

Citations

8

H-Index

15

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

SA

About

Sunanda A. Ranadive is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	751
2	Biochemistry	3	3	438
3	Immunology	3	3	518
4	Natural Sciences	2	2	406
5	Health Sciences	1	1	251

Sunanda A. Ranadive

×

7

Publications

1.1K

Citations

7

H-Index

	Year	Citations
<i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent Raj N. Misra, Hai‐Yun Xiao, Kyoung S. Kim, Journal of Medicinal Chemistry Chemoprevention StrategyImmunologyPharmacotherapyCdk2/cyce IcPharmaceutical Chemistry	2004	251
Discovery of 4-Benzoyl-1-[(4-methoxy-1<i>H</i>- pyrrolo[2,3-<i>b</i>]pyridin-3-yl)oxoacetyl]-2- (<i>R</i>)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions Tao Wang, Zhongxing Zhang, Owen B. Wallace, Journal of Medicinal Chemistry Cd4-gp120 InteractionsPharmaceutical ScienceImmunologyPharmacotherapyDissolution-limited Absorption	2003	205
Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin Abu T.M. Serajuddin, Sunanda A. Ranadive, Eileen M. Mahoney Journal of Pharmaceutical Sciences Molecular PharmacologyMedicinal ChemistryReductase Inhibitors PravastatinPharmaceutical ScienceBiochemistry	1991	201
Selection of solid dosage form composition through drug–excipient compatibility testing Abu T.M. Serajuddin, Ajit B. Thakur, Rabin N. Ghoshal, Journal of Pharmaceutical Sciences	1999	200
Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors Sunanda A. Ranadive, Andrew Chen, Abu T.M. Serajuddin Pharmaceutical Research	1992	118
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns Nicholas A. Meanwell, Owen B. Wallace, Haiquan Fang, Bioorganic & Medicinal Chemistry Letters Initial SurveyMedicineHuman RetrovirusIndole Substitution PatternsImmunology	2009	62
Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development Kenneth R. Morris, Ann Newman, D.E. Bugay, International Journal of Pharmaceutics Protein ChemistryBiochemistryMedicineCrystal PropertiesStructure-function Enzyme Kinetics	1994	32

Page 1